NCT07745361
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07745361
Title Study of Oral MRT-2359 With Apalutamide in Prostate Cancer (MODeFIRe-1)
Acronym MODeFIRe-1
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Monte Rosa Therapeutics, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
START Los Angeles RECRUITING Los Angeles California 90025 United States Details
Hoag Memorial Hospital Presbyterian NOT_YET_RECRUITING Newport Beach California 92663 United States Details
Rocky Mountain Cancer Center NOT_YET_RECRUITING Colorado Springs Colorado 80907 United States Details
Kansas University Cancer Center NOT_YET_RECRUITING Kansas City Kansas 66160 United States Details
University of Maryland Greenebaum Cancer Center NOT_YET_RECRUITING Baltimore Maryland 21201 United States Details
Henry Ford NOT_YET_RECRUITING Novi Michigan 48377 United States Details
XCancer Omaha NOT_YET_RECRUITING Omaha Nebraska 68130 United States Details
START New Jersey RECRUITING East Brunswick New Jersey 08816 United States Details
Levine Cancer Institute NOT_YET_RECRUITING Charlotte North Carolina 28204 United States Details
Lancaster Urology NOT_YET_RECRUITING Lancaster Pennsylvania 17601 United States Details
Sarah Cannon Research Institute NOT_YET_RECRUITING Nashville Tennessee 37203 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
Virginia Cancer Specialists NOT_YET_RECRUITING Fairfax Virginia 22031 United States Details
University of Washington Medical Center NOT_YET_RECRUITING Seattle Washington 98195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field